oxprenolol has been researched along with Metabolic Diseases in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walldius, G | 1 |
1 other study available for oxprenolol and Metabolic Diseases
| Article | Year |
|---|---|
What happens after lipoprotein lipase? A low fatty acid incorporation into adipose tissue (FIAT) in hypertriglyceridaemia-experimental and clinical studies.
Topics: Adipose Tissue; Adult; Aged; Clofibrate; Fatty Acids; Glucose; Humans; Lipolysis; Lipoprotein Lipase | 1981 |